Intelligence · Clinical pipeline
Phase II Pipeline Programs
Proof-of-concept and dose-finding clinical programs in Phase II development.
Quick answer
NovaPharmaNews tracks 7,238 phase ii pharmaceutical pipeline programs from ClinicalTrials.gov. Proof-of-concept and dose-finding clinical programs in Phase II development.
Top sponsors
- Chinese Academy of 432 programs
- BRIGHT MINDS BIOSCIENCES 393 programs
- First People's Hospital 375 programs
- United Therapeutics Europe 336 programs
- Takeda 335 programs
- Anaxis Pharma 223 programs
- George Institute for 187 programs
- Regeneron UK 176 programs
- Teva Pharma 126 programs
- Novartis India 121 programs
- Telethon Foundation 119 programs
- Disc Medicine 106 programs
Pipeline programs
-
HTX-011B
Heron Therapeutics
Postoperative Pain
1 trial -
HTX-034
Heron Therapeutics
Bunions
1 trial -
HUMSCs combined with bovine type I collagen
The First People's Hospital of Lianyungang
Burn Wounds
1 trial -
HZNP-DAX-202
Elan Pharma International
Primary Discoid Lupus Erythematosus
1 trial -
HZNP-HZN-1116-201
Elan Pharma International
Sjögren’s Syndrome
1 trial -
HZNP-HZN-825-301
Elan Pharma International
Diffuse Cutaneous Systemic Sclerosis
1 trial -
HZNP-HZN-825-303
Elan Pharma International
Idiopathic Pulmonary Fibrosis
1 trial -
Halneuron
Dogwood Therapeutics
Chemotherapy Induced Neuropathic Pain
1 trial -
HarMono-T 5 microlitres/mL gas and solvent for dispersion for injection/infusion
Lacuna Pharma Pty Ltd
Ultrasound contrast agent, for diagnostic purposes (to assess indeterminate kidney lesions)
1 trial -
Heart Rate Variability Biofeedback
BRIGHT MINDS BIOSCIENCES INC.
Tobacco Smoking
1 trial -
Heparin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Thromboprophylaxis
1 trial -
Heparin and Rivaroxaban
The First People's Hospital of Lianyungang
Liver Cirrhosis
1 trial -
Hepatitis A Vaccine
Takeda
Healthy Volunteers
1 trial -
Herbal Medicine C-117
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Occlusion and Stenosis of Unspecified Cerebral Artery
1 trial -
Heroin Dependence
BRIGHT MINDS BIOSCIENCES INC.
Heroin Dependence
1 trial -
Herombopag
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Non Severe Aplastic Anemia
1 trial -
Herombopag
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Chemotherapy-induced Thrombocytopenia
1 trial -
Herzuma
Vera Therapeutics
HER2 Enriched Subtype Breast Cancer, Herzuma, PAM50 Study
1 trial -
HiPSC-RPE cells
The First People's Hospital of Lianyungang
AMD - Age-Related Macular Degeneration
1 trial -
High Dose SAB-142
SAB Biotherapeutics
Type 1 Diabetes
1 trial -
High-Low Dose Radiotherapy
Jian Li
Nasopharyngeal Carcinoma (NPC)
1 trial -
High-dose donepezil
BRIGHT MINDS BIOSCIENCES INC.
Cocaine Use Disorders
1 trial -
Homoharringtonine
Teva Pharma GmbH
Myeloid Leukemia, Chronic
1 trial -
Humalog
HALOZYME THERAPEUTICS, INC.
Type 1 Diabetes Mellitus
1 trial -
Humalog
HALOZYME THERAPEUTICS, INC.
Diabetes Mellitus, Type 2
1 trial -
Human Adipose-Derived Stem Cell Exosomes
The First People's Hospital of Lianyungang
Acute Ischemic Stroke
1 trial -
Human COVID-19 immunoglobulin (pH4) for intravenous injection
Xiyuan Hospital of China Academy of Chinese Medical Sciences
COVID-19
1 trial -
Human Mesenchymal Stromal Cells
United Therapeutics Europe Ltd
Respiratory Distress Syndrome, Adult
1 trial -
Human Umbilical Cord derived MSCs
CytoMed Therapeutics Ltd
Lupus Nephritis
1 trial -
Humanized CD7 CAR-T cells
The First People's Hospital of Lianyungang
T Lymphoblastic Leukemia/Lymphoma
1 trial -
Humanized anti-CD117 Monoclonal Antibody (JSP191)
Jasper Therapeutics
SCID
1 trial -
Humira 40 mg solution for injection in pre-filled syringe
Disc Medicine
Inflammatory Bowel Disease (IBD)
1 trial -
Huzhang granule
Universal Integrated
Gouty Arthritis
1 trial -
Hyaluronidase
Amphastar France Pharmaceuticals
Allergic Skin Reaction
1 trial -
Hydrocortisone Modified Release Capsules
NEUROCRINE BIOSCIENCES INC
Endocrine Disease
1 trial -
Hydrocortisone acetate and lidocaine hydrochloride
CITIUS ONCOLOGY, INC.
Hemorrhoids
1 trial -
Hydrogel of spirulina-derived exosomes.
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Radiation-induced Esophagitis
1 trial -
Hydrogen Peroxide
United Therapeutics Europe Ltd
Breast Cancer
1 trial -
Hydroxycarbamid
BRIGHT MINDS BIOSCIENCES INC.
Central Retinal Vein Occlusion, Non-Ischemic
1 trial -
Hydroxychloroquine (HCQ)
Teva Pharma GmbH
COVID-19
1 trial -
Hydroxyproline and Leucine
Ultragenyx UK Limited
Hyperoxaluria
1 trial -
Hydroxypropyl Guar Galactomannan
Alcon Laboratories (Australia) Pty Ltd
Dry Eye Disease
1 trial -
Hydroxyurea
Sana Biotechnology
Thalassemia, Beta
1 trial -
Hyperbaric Oxygen Therapy
Summit Therapeutics
TBI Traumatic Brain Injury
1 trial -
Hyperbolic
Talion
non-small cell lung cancer (NSCLC)
1 trial -
Hyperimmune plasma
Lxo Ireland Designated Activity Company
SARS-CoV 2
1 trial -
Hyperpolarized 129Xenon gas
United Therapeutics Europe Ltd
Pulmonary Vascular Disease
1 trial -
Hyperpolarized 13C-Pyruvate injection
Hospital Authority, Hong Kong
Gynecologic Cancer
1 trial
Frequently asked questions
How many Phase II pipeline programs are in the directory?
7,238 published programs match this development stage in our ClinicalTrials.gov index.
What defines this pipeline stage?
Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.